{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:42:45Z","timestamp":1792690965784,"version":"4.5.0"},"reference-count":55,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,9,27]]},"DOI":"10.1136\/thorax-2026-224997","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:20:35Z","timestamp":1792689635000},"page":"thorax-2026-224997","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Guideline adherence to invasive mediastinal staging in contemporary resectable NSCLC trials: a systematic review"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0121-2155","authenticated-orcid":false,"given":"Belinda Maricela","family":"Contreras-Garza","sequence":"first","affiliation":[{"name":"Unidad M\u00e9dica de Alta Especialidad Hospital de Cardiolog\u00eda No 34, Monterrey, Mexico"},{"name":"Centro de Neumolog\u00eda y Oncolog\u00eda Toracica, Monterrey, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Flores-Mejia","sequence":"additional","affiliation":[{"name":"Centro de Neumolog\u00eda y Oncolog\u00eda Toracica, Monterrey, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Martinez-Valenciano","sequence":"additional","affiliation":[{"name":"Centro de Neumolog\u00eda y Oncolog\u00eda Tor\u00e1cica, Monterrey, Nuevo Le\u00f3n, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sanchez-Soto","sequence":"additional","affiliation":[{"name":"Unidad M\u00e9dica de Alta Especialidad Hospital de Cardiolog\u00eda No 34, Monterrey, N.L, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolenny","family":"Jimenez-Lopez","sequence":"additional","affiliation":[{"name":"Centro de Neumolog\u00eda y Oncolog\u00eda Toracica, Monterrey, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Elena","family":"Guzm\u00e1n-Delgado","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de Educaci\u00f3n e Investigaci\u00f3n en Salud, Unidad Medica de Alta Especialidad Hospital de Cardiologia No 34, Monterrey, N.L, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Yaneth","family":"Contreras-Garza","sequence":"additional","affiliation":[{"name":"Tecnologico de Monterrey Escuela de Medicina y Ciencias de la Salud, Monterrey, N.L, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102210202454000_thorax-2026-224997v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00312-3"},{"key":"2026102210202454000_thorax-2026-224997v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2023.04.039"},{"key":"2026102210202454000_thorax-2026-224997v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2025.06.023"},{"key":"2026102210202454000_thorax-2026-224997v1.4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/resp.13827","article-title":"Lung cancer staging: State of the art in the era of ablative therapies and surgical segmentectomy","volume":"25","author":"Gregor","year":"2020","journal-title":"Respirology"},{"key":"2026102210202454000_thorax-2026-224997v1.5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jtho.2022.12.009","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer","volume":"18","author":"Osarogiagbon","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2026102210202454000_thorax-2026-224997v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.10.020"},{"key":"2026102210202454000_thorax-2026-224997v1.7","article-title":"PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer","volume":"2014","author":"Schmidt-Hansen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102210202454000_thorax-2026-224997v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2007.03.081"},{"key":"2026102210202454000_thorax-2026-224997v1.9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(24)00010-9","article-title":"Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial","volume":"12","author":"Steinfort","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026102210202454000_thorax-2026-224997v1.10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00126714"},{"key":"2026102210202454000_thorax-2026-224997v1.11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-1362"},{"key":"2026102210202454000_thorax-2026-224997v1.12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1392040"},{"key":"2026102210202454000_thorax-2026-224997v1.13","doi-asserted-by":"crossref","unstructured":"Silvestri GA , Gonzalez AV , Jantz MA , et al . Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer. Chest 2013;143. doi:10.1378\/chest.12-2355","DOI":"10.1378\/chest.12-2355"},{"key":"2026102210202454000_thorax-2026-224997v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu028"},{"key":"2026102210202454000_thorax-2026-224997v1.15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00097-2026","article-title":"ERS\/ESGE\/ESTS clinical practice guidelines on endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer","volume":"68","author":"Korevaar","year":"2026","journal-title":"Eur Respir J"},{"key":"2026102210202454000_thorax-2026-224997v1.16","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2026.0017","article-title":"Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology","volume":"24","author":"Riely","year":"2026","journal-title":"J Natl Compr Canc Netw"},{"key":"2026102210202454000_thorax-2026-224997v1.17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.athoracsur.2017.02.074","article-title":"Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer","volume":"104","author":"Ghaly","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2026102210202454000_thorax-2026-224997v1.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703413"},{"key":"2026102210202454000_thorax-2026-224997v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2009.12.013"},{"key":"2026102210202454000_thorax-2026-224997v1.20","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/89.9.873"},{"key":"2026102210202454000_thorax-2026-224997v1.21","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102210202454000_thorax-2026-224997v1.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202170"},{"key":"2026102210202454000_thorax-2026-224997v1.23","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1158\/2159-8290.CD-23-0436","article-title":"Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial","volume":"13","author":"Cascone","year":"2023","journal-title":"Cancer Discov"},{"key":"2026102210202454000_thorax-2026-224997v1.24","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1038\/s41591-025-03746-z","article-title":"Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial","volume":"31","author":"Cascone","year":"2025","journal-title":"Nat Med"},{"key":"2026102210202454000_thorax-2026-224997v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30453-8"},{"key":"2026102210202454000_thorax-2026-224997v1.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304875"},{"key":"2026102210202454000_thorax-2026-224997v1.27","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz064.014","article-title":"IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy","volume":"30","author":"Peters","year":"2019","journal-title":"Annals of Oncology"},{"key":"2026102210202454000_thorax-2026-224997v1.28","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1200\/JCO.21.00276","article-title":"Swiss Group for Clinical Cancer Research (SAKK","volume":"39","author":"Rothschild","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026102210202454000_thorax-2026-224997v1.29","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/j.clon.2021.07.008","article-title":"Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB\/IIIA Non-small Cell Lung Cancer \u2013 A Phase II trial","volume":"33","author":"Mittal","year":"2021","journal-title":"Clin Oncol"},{"key":"2026102210202454000_thorax-2026-224997v1.30","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-024-02965-0","article-title":"Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial","volume":"30","author":"Schuler","year":"2024","journal-title":"Nat Med"},{"key":"2026102210202454000_thorax-2026-224997v1.31","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1996000","article-title":"Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer","volume":"10","author":"Zhao","year":"2021","journal-title":"Oncoimmunology"},{"key":"2026102210202454000_thorax-2026-224997v1.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302983"},{"key":"2026102210202454000_thorax-2026-224997v1.33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.athoracsur.2022.01.039","article-title":"Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer","volume":"114","author":"Zhang","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"2026102210202454000_thorax-2026-224997v1.34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005636","article-title":"Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)","volume":"10","author":"Wislez","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026102210202454000_thorax-2026-224997v1.35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jtho.2023.02.019","article-title":"Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial","volume":"18","author":"Zhao","year":"2023","journal-title":"Journal of Thoracic Oncology"},{"key":"2026102210202454000_thorax-2026-224997v1.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215530"},{"key":"2026102210202454000_thorax-2026-224997v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30140-6"},{"key":"2026102210202454000_thorax-2026-224997v1.38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24735"},{"key":"2026102210202454000_thorax-2026-224997v1.39","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.21037\/tlcr-21-130","article-title":"Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study","volume":"10","author":"Duan","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"2026102210202454000_thorax-2026-224997v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00149-2"},{"key":"2026102210202454000_thorax-2026-224997v1.41","doi-asserted-by":"crossref","first-page":"102422","DOI":"10.1016\/j.eclinm.2024.102422","article-title":"Efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy in potentially resectable stage IIIA\/IIIB non-small cell lung cancer: Neo-Pre-IC, a single-arm phase 2 trial","volume":"68","author":"Sun","year":"2024","journal-title":"eClinicalMedicine"},{"key":"2026102210202454000_thorax-2026-224997v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01962-5"},{"key":"2026102210202454000_thorax-2026-224997v1.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2311926"},{"key":"2026102210202454000_thorax-2026-224997v1.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01224-2"},{"key":"2026102210202454000_thorax-2026-224997v1.45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41392-023-01700-4","article-title":"Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study","volume":"8","author":"Liu","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"2026102210202454000_thorax-2026-224997v1.46","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jtho.2025.09.031","article-title":"OA02.01 SKYSCRAPER-05: Phase II Study of Perioperative Tiragolumab + Atezolizumab \u00b1Chemotherapy in Locally Advanced Resectable NSCLC","volume":"20","author":"Pass","year":"2025","journal-title":"Journal of Thoracic Oncology"},{"key":"2026102210202454000_thorax-2026-224997v1.47","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jamaoncol.2023.2751","article-title":"Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non-Small Cell Lung Cancer: The TD-FOREKNOW Randomized Clinical Trial","volume":"9","author":"Lei","year":"2023","journal-title":"JAMA Oncol"},{"key":"2026102210202454000_thorax-2026-224997v1.48","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO-25-00883","article-title":"NeoADAURA Investigators","volume":"43","author":"He","year":"2025","journal-title":"J Clin Oncol"},{"key":"2026102210202454000_thorax-2026-224997v1.49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.lungcan.2023.02.011","article-title":"Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial","volume":"178","author":"Lv","year":"2023","journal-title":"Lung Cancer"},{"key":"2026102210202454000_thorax-2026-224997v1.50","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1200\/JCO.24.00071","article-title":"Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study","volume":"42","author":"Blakely","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026102210202454000_thorax-2026-224997v1.51","unstructured":"Leonetti A , Boni L , Gnetti L , et al . Alectinib as neoadjuvant treatment in potentially resectable stage iii alk-positive nsclc. 2025."},{"key":"2026102210202454000_thorax-2026-224997v1.52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jtcvs.2020.02.131","article-title":"Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non-small cell lung cancer: A phase II study","volume":"161","author":"Zhang","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026102210202454000_thorax-2026-224997v1.53","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40349-z","article-title":"Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study","volume":"14","author":"Bian","year":"2023","journal-title":"Nat Commun"},{"key":"2026102210202454000_thorax-2026-224997v1.54","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/j.semtcvs.2019.07.007","article-title":"Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients","volume":"32","author":"Hegde","year":"2020","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2026102210202454000_thorax-2026-224997v1.55","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/ejcts\/ezw400","article-title":"Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients","volume":"51","author":"Bille","year":"2017","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-224997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:20:40Z","timestamp":1792689640000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-224997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":55,"alternative-id":["10.1136\/thorax-2026-224997"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-224997","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}